Charles River Laboratories International, Inc.
Price Action
Technical Summary
EMERGING TRENDCharles River Laboratories International, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is weak (RS Rating: 33), showing significant lag compared to the market leaders. Earnings contraction of 33% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $175.76 | +3.39% | ABOVE |
| 50 SMA | $170.37 | +6.67% | ABOVE |
| 100 SMA | $184.72 | -1.62% | BELOW |
| 150 SMA | $181.97 | -0.13% | BELOW |
| 200 SMA | $176.34 | +3.05% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CRL in an uptrend right now?
CRL has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is CRL overbought or oversold?
CRL's RSI (14) is 61. The stock is in neutral territory, neither overbought nor oversold.
Is CRL outperforming the market?
CRL has a Relative Strength (RS) Rating of 33 out of 99. CRL is currently lagging the broader market.
Where is CRL in its 52-week range?
CRL is trading at $181.73, which is 79% of its 52-week high ($228.88) and 52% above its 52-week low ($131.30).
How volatile is CRL?
CRL has a Beta of 1.52 and 52-week volatility of 46%. It's more volatile than the S&P 500 - expect bigger swings.